Brazil Mandates Workplace Health Communication on Cancer and Vaccination
Brazilian companies must now inform employees about cancer diagnostics and HPV vaccination under new law, coupled with advancements in cancer treatment production for public health.
- • New regulation mandates companies to inform employees about HPV vaccination and cancers.
- • Employers must comply with Ministry of Health guidelines starting April 6, 2026.
- • Employees can take leave for preventive cancer exams without pay loss.
- • Butantan Institute partners with MSD to produce pembrolizumab for SUS users.
- • Pembrolizumab is an immune therapy less toxic than chemotherapy.
Key details
Starting April 6, 2026, Brazilian companies are required by new legislation to inform their employees about human papillomavirus (HPV) vaccination campaigns and diagnostic services for breast, prostate, and cervical cancers. This obligation amends the Consolidation of Labor Laws, ensuring employer communication complies with the Ministry of Health's guidelines. Workers are also entitled to paid leave for undergoing preventive examinations, reinforcing preventive health measures in the workplace.
In addition to this regulatory change, the Butantan Institute has partnered with U.S.-based pharmaceutical firm MSD to produce pembrolizumab for patients within Brazil's public health system, the SUS. Pembrolizumab is an immunotherapy drug that enhances the immune system's ability to target and destroy cancer cells and is noted for being less toxic compared to traditional chemotherapy. This collaboration emerged from a Ministry of Health call for proposals in 2024 and signifies progress in accessible, advanced cancer therapies for the Brazilian population.
These developments mark a significant public health advance, promoting awareness, prevention, and treatment accessibility for cancers among Brazilian workers while advancing pharmaceutical innovation in the country.
This article was translated and synthesized from Brazilian sources, providing English-speaking readers with local perspectives.
